vs

Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and Sprout Social, Inc. (SPT). Click either name above to swap in a different company.

iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $120.9M, roughly 1.7× Sprout Social, Inc.). On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 12.9%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $9.9M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 11.8%).

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

Sprout Social, Inc. is a technology company that runs a social media management platform. A public company headquartered in Chicago, it was founded in 2010 by Justyn Howard, Aaron Rankin, Gil Lara, and Peter Soung.

IRTC vs SPT — Head-to-Head

Bigger by revenue
IRTC
IRTC
1.7× larger
IRTC
$208.9M
$120.9M
SPT
Growing faster (revenue YoY)
IRTC
IRTC
+14.2% gap
IRTC
27.1%
12.9%
SPT
More free cash flow
IRTC
IRTC
$4.6M more FCF
IRTC
$14.5M
$9.9M
SPT
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
11.8%
SPT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRTC
IRTC
SPT
SPT
Revenue
$208.9M
$120.9M
Net Profit
$5.6M
Gross Margin
70.9%
77.6%
Operating Margin
1.1%
-9.0%
Net Margin
2.7%
Revenue YoY
27.1%
12.9%
Net Profit YoY
518.5%
EPS (diluted)
$0.18
$-0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRTC
IRTC
SPT
SPT
Q4 25
$208.9M
$120.9M
Q3 25
$192.9M
$115.6M
Q2 25
$186.7M
$111.8M
Q1 25
$158.7M
$109.3M
Q4 24
$164.3M
$107.1M
Q3 24
$147.5M
$102.6M
Q2 24
$148.0M
$99.4M
Q1 24
$131.9M
$96.8M
Net Profit
IRTC
IRTC
SPT
SPT
Q4 25
$5.6M
Q3 25
$-5.2M
$-9.4M
Q2 25
$-14.2M
$-12.0M
Q1 25
$-30.7M
$-11.2M
Q4 24
$-1.3M
Q3 24
$-46.2M
$-17.1M
Q2 24
$-20.1M
$-16.9M
Q1 24
$-45.7M
$-13.6M
Gross Margin
IRTC
IRTC
SPT
SPT
Q4 25
70.9%
77.6%
Q3 25
71.1%
77.7%
Q2 25
71.2%
77.7%
Q1 25
68.8%
77.3%
Q4 24
70.0%
78.1%
Q3 24
68.8%
77.4%
Q2 24
69.9%
77.5%
Q1 24
66.3%
76.8%
Operating Margin
IRTC
IRTC
SPT
SPT
Q4 25
1.1%
-9.0%
Q3 25
-4.4%
-7.9%
Q2 25
-10.0%
-11.0%
Q1 25
-20.5%
-10.2%
Q4 24
-2.5%
-12.8%
Q3 24
-34.1%
-16.4%
Q2 24
-15.5%
-16.6%
Q1 24
-28.9%
-13.7%
Net Margin
IRTC
IRTC
SPT
SPT
Q4 25
2.7%
Q3 25
-2.7%
-8.1%
Q2 25
-7.6%
-10.7%
Q1 25
-19.3%
-10.3%
Q4 24
-0.8%
Q3 24
-31.3%
-16.6%
Q2 24
-13.6%
-17.0%
Q1 24
-34.6%
-14.0%
EPS (diluted)
IRTC
IRTC
SPT
SPT
Q4 25
$0.18
$-0.18
Q3 25
$-0.16
$-0.16
Q2 25
$-0.44
$-0.21
Q1 25
$-0.97
$-0.19
Q4 24
$-0.03
$-0.25
Q3 24
$-1.48
$-0.30
Q2 24
$-0.65
$-0.30
Q1 24
$-1.47
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRTC
IRTC
SPT
SPT
Cash + ST InvestmentsLiquidity on hand
$583.8M
$95.3M
Total DebtLower is stronger
$40.0M
Stockholders' EquityBook value
$152.7M
$203.4M
Total Assets
$1.0B
$523.1M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRTC
IRTC
SPT
SPT
Q4 25
$583.8M
$95.3M
Q3 25
$565.2M
$90.6M
Q2 25
$545.5M
$101.5M
Q1 25
$520.6M
$100.9M
Q4 24
$535.6M
$86.4M
Q3 24
$522.0M
$82.9M
Q2 24
$561.5M
$80.9M
Q1 24
$569.1M
$69.2M
Total Debt
IRTC
IRTC
SPT
SPT
Q4 25
$40.0M
Q3 25
Q2 25
Q1 25
Q4 24
$25.0M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IRTC
IRTC
SPT
SPT
Q4 25
$152.7M
$203.4M
Q3 25
$121.9M
$194.1M
Q2 25
$103.7M
$184.6M
Q1 25
$86.7M
$175.3M
Q4 24
$90.9M
$166.6M
Q3 24
$71.8M
$158.1M
Q2 24
$99.2M
$152.1M
Q1 24
$90.3M
$147.3M
Total Assets
IRTC
IRTC
SPT
SPT
Q4 25
$1.0B
$523.1M
Q3 25
$995.2M
$481.4M
Q2 25
$964.0M
$422.9M
Q1 25
$926.1M
$424.7M
Q4 24
$931.4M
$428.3M
Q3 24
$909.7M
$388.8M
Q2 24
$919.2M
$393.6M
Q1 24
$909.8M
$389.9M
Debt / Equity
IRTC
IRTC
SPT
SPT
Q4 25
0.20×
Q3 25
Q2 25
Q1 25
Q4 24
0.15×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRTC
IRTC
SPT
SPT
Operating Cash FlowLast quarter
$26.2M
$10.9M
Free Cash FlowOCF − Capex
$14.5M
$9.9M
FCF MarginFCF / Revenue
6.9%
8.2%
Capex IntensityCapex / Revenue
5.6%
0.9%
Cash ConversionOCF / Net Profit
4.70×
TTM Free Cash FlowTrailing 4 quarters
$34.5M
$39.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRTC
IRTC
SPT
SPT
Q4 25
$26.2M
$10.9M
Q3 25
$34.9M
$9.3M
Q2 25
$27.7M
$5.1M
Q1 25
$-7.9M
$18.1M
Q4 24
$19.2M
$4.1M
Q3 24
$24.3M
$9.0M
Q2 24
$11.8M
$2.1M
Q1 24
$-52.0M
$11.2M
Free Cash Flow
IRTC
IRTC
SPT
SPT
Q4 25
$14.5M
$9.9M
Q3 25
$20.1M
$8.5M
Q2 25
$17.3M
$4.2M
Q1 25
$-17.3M
$16.7M
Q4 24
$12.4M
$3.3M
Q3 24
$15.5M
$8.5M
Q2 24
$3.4M
$1.6M
Q1 24
$-61.8M
$10.1M
FCF Margin
IRTC
IRTC
SPT
SPT
Q4 25
6.9%
8.2%
Q3 25
10.4%
7.4%
Q2 25
9.3%
3.7%
Q1 25
-10.9%
15.3%
Q4 24
7.5%
3.0%
Q3 24
10.5%
8.3%
Q2 24
2.3%
1.6%
Q1 24
-46.8%
10.4%
Capex Intensity
IRTC
IRTC
SPT
SPT
Q4 25
5.6%
0.9%
Q3 25
7.7%
0.7%
Q2 25
5.6%
0.8%
Q1 25
5.9%
1.2%
Q4 24
4.2%
0.8%
Q3 24
6.0%
0.5%
Q2 24
5.7%
0.5%
Q1 24
7.4%
1.1%
Cash Conversion
IRTC
IRTC
SPT
SPT
Q4 25
4.70×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

SPT
SPT

Segment breakdown not available.

Related Comparisons